Anavex Life Sciences Corp (AVXL)

[falconer66a]

Negative Evidence Evermore Flimsy

The first leak of positive trial results from the short Rett or Parkinson’s Anavex 2-73 trials this winter is going to change the tone and themes of Anavex postings on this board. More importantly, the Anavex stories will ascend to national and international prominence, given the magnitude of the social and economic problems Anavex Life Sciences Corp will so successfully address. Imagine the headlines, yourself.

The desperation in posting negating “information” about the “untested, probably unsafe” Anavex drugs on this board will be ever more tenuous, if not, then, ludicrous.

Even as now, the due diligence of the many AVXL investors scrutinizing all of the Ihub Anavex postings will continue to suppress share sales and promote new, larger, stronger equity positions.

Those few with short positions, or those supporting such, really can’t be sleeping better each night. There simply has not been the expected, growing consensus, by any group, that the Anavex story is a flawed or contrived one. Just the opposite. Not a single PhD has been quoted claiming such. Many tens of thousands of shares continue be held and purchased by mutual funds. Professional organizations, such as the Rett Foundation and The Michael J. Fox Foundation (Parkinson’s Disease) are supporting Anavex trials.

The Anavex ship may still be docked in the harbor. But it’s not sinking by any means. It’s being loaded, and when it sails in 2018 it will both reward AVXL share holders and revolutionize 21st-century medicine.